TearLab (TEAR) Reports In-Line Q2 EPS

TearLab (NASDAQ: TEAR) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.95 million.

For earnings history and earnings-related data on TearLab (TEAR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c